GlaxoSmithKline PLC will pay $6 million to resolve a lawsuit by Louisiana alleging it illegally tried to delay generic versions of its allergy spray Flonase, ending the drugmaker's appeal to the U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback